Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

Item
http://www.wikidata.org/entity/Q34488678
Incidence and implications of chemotherapy related hand-foot syndrome.Multikinase Inhibitor-Induced Hand-Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and Management.Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trialClinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.Cutaneous side effects of new antitumor drugs: clinical features and managementCoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer.Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot studyTreatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report.Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials.Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.Risk Factors Exacerbating Hand-Foot Skin Reaction Induced by Capecitabine plus Oxaliplatin with or without Bevacizumab Therapy.Curcuma longa (Turmeric) for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Pilot Study.ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
P2860

Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

Item
http://www.wikidata.org/entity/Q34488678
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@ast
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@en
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@nl
type
label
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@ast
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@en
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@nl
prefLabel
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@ast
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@en
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Placebo-controlled trial to de ...... r Treatment Group Study N05C5.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932